During recent decades, many studies have investigated
|
|
- Amie Osborne
- 5 years ago
- Views:
Transcription
1 Differential Diagnosis of Benign and Malignant Mesothelial Proliferations on Pleural Biopsies Philip T. Cagle, MD; Andrew Churg, MD, PhD Context. Although much of the pathology literature focuses on differential diagnosis of diffuse malignant mesothelioma from other types of cancer, the primary diagnostic challenge facing the pathologist is often whether a mesothelial proliferation on a pleural biopsy represents a malignancy or a benign reactive hyperplasia. Design. Based on previous medical publications, extensive personal consultations, and experience on the United States Canadian Mesothelioma Reference Panel and the International Mesothelioma Panel, salient information was determined about interpretation of benign versus malignant mesothelial proliferations on pleural biopsies. Results. Differentiation of benign reactive mesothelial hyperplasia from diffuse malignant mesothelioma is often difficult. Benign reactive mesothelial hyperplasia may mimic many features ordinarily associated with malignancy, and diffuse malignant mesothelioma may be cytologically bland. Entrapment of benign reactive mesothelial cells within organizing pleuritis may mimic tissue invasion. Conclusions. Various histologic clues favor a benign over a malignant mesothelial proliferation and vice versa. Invasion is the most reliable criterion for determining that a mesothelial proliferation is malignant. When there is any doubt that a pleural biopsy represents a malignancy, we recommend a diagnosis of atypical mesothelial proliferation. (Arch Pathol Lab Med. 2005;129: ) During recent decades, many studies have investigated the differential diagnosis of diffuse malignant mesothelioma (DMM) versus other types of cancer, especially epithelial DMM versus adenocarcinomas metastatic to the pleura. However, the surgical pathologist not infrequently encounters a different problem with pleural biopsies, namely, whether a mesothelial proliferation represents a malignant neoplasm or a benign reactive hyperplasia Reactive pleural processes may be associated with pleural effusion and thickening of the pleura and in some cases raise the clinical possibility of malignancy. Reactive mesothelial cell hyperplasia and organizing pleuritis may demonstrate increased cellularity and reactive cytologic atypia of epithelial mesothelial cells and of spindle mesothelial cells, fibroblasts, and endothelial cells, respectively. It is not unusual for both epithelial and spindle proliferating cells to occur together in a reactive process. These benign reactive mesothelial proliferations may mimic malignancy because of high cellularity, cytologic atypia, and other histologic features, whereas some DMMs are cytologically bland and may be sampled in minimally invasive areas that disguise their malignant nature. Obviously, it is of considerable importance to patients to know that they have a benign pleural process rather than DMM or stage IV carcinoma. Accepted for publication July 14, From the Departments of Pathology, The Methodist Hospital, Houston, Tex (Dr Cagle); and University of British Columbia, Vancouver (Dr Churg). The authors have no relevant financial interest in the products or companies described in this article. Reprints: Philip T. Cagle, MD, Department of Pathology, The Methodist Hospital, 6565 Fannin St, Main Bldg Room 227, Houston, TX ( pcagle@tmh.tmc.edu). Biopsies that include DMM in the differential diagnosis can be referred to the United States Canadian Mesothelioma Reference Panel for the opinions of a panel of experts. In 22% of 217 cases circulated to the entire United States Canadian Mesothelioma Reference Panel between 1994 and 1999, 1 or more panelists disagreed with the majority on whether the case represented a benign reactive proliferation or a malignancy. 6 Only difficult cases are circulated to the entire panel, but this rate of disagreement among experts highlights the diagnostic dilemma that can be posed by the question of benign reactive proliferation versus malignancy on pleural biopsy. APPROACH TO THE DIFFERENTIAL DIAGNOSIS As with biopsies from other sites, it is always best to interpret pleural biopsies within the clinical context, including clinical history and findings as well as radiologic findings. Pleural processes that may be associated with benign reactive mesothelial hyperplasia and/or organizing pleuritis on a pleural biopsy are listed in Table 1. A unilateral, bloody pleural effusion is characteristic of many pleural effusions caused by malignancy, but several benign processes listed in Table 1 may be unilateral and some (pulmonary infarct, pneumothorax, surgery, trauma) may produce bloody effusions. Occasionally, a patient has exuberant pleuritis overlying a subpleural lung cancer that may or may not be invasive into the pleura, and the radiology may be very helpful in understanding the full context of the biopsy. A history of asbestos exposure should not be given any inordinate weight in making a diagnosis of DMM for at least 3 reasons: (1) asbestos exposure can cause benign pleural effusions, benign pleural plaques, and benign mesothelial reactions, and these outnumber malignant me- Arch Pathol Lab Med Vol 129, November 2005 Mesothelial Proliferations on Pleural Biopsies Cagle & Churg 1421
2 Figure 1. High-power view shows flat, inconspicuous normal mesothelial cells lining the visceral pleural surface (hematoxylin-eosin, original magnification 300). Figure 2. Simple mesothelial hyperplasia shows a more conspicuous layer of relatively bland cuboidal cells regularly spaced along the pleural surface (hematoxylin-eosin, original magnification 350) Arch Pathol Lab Med Vol 129, November 2005 Mesothelial Proliferations on Pleural Biopsies Cagle & Churg
3 Table 1. Causes of Benign Reactive Mesothelial Hyperplasia and Organizing Pleuritis Infections Collagen vascular diseases Pulmonary infarcts Drug reactions Pneumothorax Subpleural lung carcinomas Surgery Trauma Nonspecific Table 2. Features of Benign Reactive Mesothelial Hyperplasia That May Mimic Malignancy High cellularity Cytologic atypia/mitoses Necrosis Papillary excrescences or lumens Entrapment (pseudoinvasion with benign mesothelial cells entrapped in organizing pleuritis) sotheliomas; (2) asbestos exposure is fairly common and asbestos-exposed individuals are susceptible to the same nonasbestos causes of pleural effusions and reactions as everyone else; and (3) not all DMMs are caused by asbestos exposure. The impression of the surgeon on thoracoscopic or thoracotomy examination is helpful information. Classically, malignancies involving the pleura appear as multiple tumor nodules or encasement of the pleura by tumor. However, gross appearances may occasionally be misleading and, if the biopsy is not conclusive for malignancy, it is recommended that the pathologist not yield to pressure to make a diagnosis of malignancy based solely on reported gross impressions. On the other hand, if the surgeon states that the process appears benign on thoracoscopic or thoracotomy examination, the pathologist should be circumspect about diagnosing malignancy. Histologic features of benign reactive mesothelial hyperplasia that may potentially mimic histologic features of malignancy are listed in Table 2. In subsequent sections, we discuss the histologic features of mesothelial proliferations that can be encountered on a pleural biopsy. Diagnosis of malignancy on pleural biopsy may be problematic not only because of potential benign reactive mesothelial hyperplasia, but also because of sampling and other issues that may limit the usefulness of any biopsy. We advocate a very guarded approach to the diagnosis of malignancy on pleural biopsies when a reactive mesothelial proliferation is in the differential diagnosis. Given the consequences to the patient of a diagnosis of malignant mesothelioma, when there is any doubt about malignancy on a pleural biopsy, we recommend the term atypical mesothelial proliferation or atypical mesothelial hyperplasia be used for the diagnosis and additional tissue obtained if clinically indicated. MESOTHELIAL PROLIFERATIONS LIMITED TO THE PLEURAL SURFACE If a pleural biopsy shows only mesothelial cells along the surface with no mesothelial cells observed in the underlying tissue, the proliferation may represent simple mesothelial cell hyperplasia or atypical mesothelial hyperplasia. It is likely that some instances of the latter represent mesothelioma in situ, but that diagnosis cannot be made with current histologic criteria unless invasive malignancy is also present. The normal mesothelial lining of the pleura is composed of flat cells that are inconspicuous on casual histologic examination (Figure 1). Irritation of the pleural surface leads to simple hyperplasia of the mesothelium. The mesothelial cells in simple hyperplasia form a more conspicuous layer of relatively bland cuboidal cells regularly spaced along the pleural surface (Figure 2). Distinct nucleoli may sometimes be present. The hyperplastic cells usually show regular spacing along the membrane. Atypical mesothelial hyperplasia is a more florid mesothelial proliferation along the pleural surface than simple hyperplasia. There is a spectrum of cytologic atypia and cellularity between cases of simple hyperplasia to cases of atypical mesothelial hyperplasia that are worrisome for noninvasive malignancy. Atypical mesothelial hyperplasia may consist of a single layer of cells with varying degrees of cytologic atypia along the surface (Figure 3) or may consist of piled-up accumulations of cells on the surface (Figure 4). The cells of atypical mesothelial hyperplasia are cuboidal to elongate, may have enlarged nuclei, and often have prominent nucleoli with significant cell-tocell variation (Figures 5 and 6). Simple mesothelial hyperplasia is usually not of diagnostic concern and clearly represents a benign reactive process. Some examples of atypical mesothelial hyperplasia represent the more cellular and more cytologically atypical spectrum of benign reactive processes, whereas other examples probably represent noninvasive malignancy, either at the margin of an invasive tumor or possibly a preinvasive stage of malignancy. Inflammatory changes and clinical history/findings of a benign process favor a benign reaction, and a lack of inflammatory changes or dense underlying fibrosis may increase concern for a malignancy, but neither situation is definitive. On the other hand, bulk tumor in nodules or masses on the pleural surface should be considered malignant (Figure 7). Progressive morphologic steps from normal epithelium through varying degrees of dysplasia to carcinoma in situ Figure 3. This mesothelium demonstrates minimal features of atypical mesothelial hyperplasia consisting of a single layer of cells along the pleural surface with minimal to mild cytologic atypia (hematoxylin-eosin, original magnification 350). Figure 4. This example of atypical mesothelial hyperplasia consists of piled-up cuboidal to elongate cells with nuclear atypia and prominent nucleoli in many cells. There are papillary-like tufts of cells projecting into the pleural space (hematoxylin-eosin, original magnification 300). Figure 5. Atypical mesothelial hyperplasia with proliferating mesothelial cells piled up above the pleural surface. Some of the cells have prominent nucleoli (hematoxylin-eosin, original magnification 350). Figure 6. Atypical mesothelial hyperplasia composed of cytologically atypical cells with prominent nucleoli and papillary tufts. This histology is suggestive of malignancy, but is not definitive and no invasion was identified in the biopsy (hematoxylin-eosin, original magnification 350). Arch Pathol Lab Med Vol 129, November 2005 Mesothelial Proliferations on Pleural Biopsies Cagle & Churg 1423
4 Figure 7. Bulk tumor on the pleural surface, as shown here, should be considered malignant (hematoxylin-eosin, original magnification 150). Figure 8. Very early stage tubulopapillary diffuse malignant mesothelioma (DMM) on the visceral surface has microfoci of superficial invasion. These types of lesions and extrapolation from other types of cancers lead many to believe that there is a preinvasive stage of DMM. Currently, there are no reliable criteria to separate mesothelioma in situ from reactive mesothelial hyperplasia and, therefore, we recommend against making diagnoses of mesothelioma in situ at the present time (hematoxylin-eosin, original magnification 250). Figure 9. Bland necrosis of a sarcomatous diffuse malignant mesothelioma (DMM) is seen in the lower left half of the figure. Bland necrosis, consisting of ischemic-type necrosis without significant inflammatory cells or cellular debris, is characteristic of DMM, as opposed to benign reactive processes (hematoxylin-eosin, original magnification 150). Figure 10. Papillary excrescences of benign mesothelial cells are seen in this reactive pleuritis. A partially en face cut also gives the impression of very superficial invasion. The mesothelial cells are very regular and bland (hematoxylin-eosin, original magnification 200) Arch Pathol Lab Med Vol 129, November 2005 Mesothelial Proliferations on Pleural Biopsies Cagle & Churg
5 Table 3. Histologic Features Favoring a Diagnosis of Malignancy Over Reactive Hyperplasia Unequivocal invasion of underlying tissues Cellular nodules with stromal expansion Cellularity of the atypical cells throughout the full thickness of the pleura (lack of zonation) Unequivocal malignant features of severe pleomorphism, atypical mitoses, etc Bland necrosis to minimally invasive malignancy are established in the cervix, lung, and other organs. Therefore, it is probable that there are preneoplastic and in situ phases in the development of DMM. 9 Some examples of atypical mesothelial hyperplasia could conceivably represent these preneoplastic and preinvasive phases of DMM. Whitaker et al 3 and Henderson et al 4 proposed potential criteria for a morphologic diagnosis of mesothelioma in situ, but noted that this diagnosis could only be confirmed when accompanied by adjacent or subsequent invasive tumor (Figure 8). Currently, there are no reliable morphologic criteria for the diagnosis of mesothelioma in situ in the absence of invasive tumor, and we suggest that the term mesothelioma in situ should not be used in diagnosis. Instead, a surface mesothelial proliferation of indeterminate malignancy should be diagnosed as atypical mesothelial hyperplasia or atypical mesothelial proliferation, with the understanding that some of these cases will eventually turn out to be benign and that others may turn out to be malignant. When in doubt, it is best to avoid a diagnosis that cannot be substantiated and instead ask for additional tissue if clinically indicated. DIAGNOSIS OF MALIGNANCY Pathologists recognize certain histologic features as being characteristic of malignancy, but are aware that some reactive processes may share degrees of these features. Mesothelial cells are particularly notorious for demonstrating greater degrees of cytologic atypia in benign reactive processes than they sometimes do when they are malignant. As is well known to cytologists, malignant mesothelial cells can be very cytologically bland. Indeed, although malignant mesothelial cells may occasionally be highly pleomorphic, the presence of highly pleomorphic cells is much more suggestive of a carcinoma than a DMM. Mitoses, which are often associated with malignancy, can be increased in a benign reactive mesothelial hyperplasia. Necrosis may occur in both DMM and benign reactive pleural processes. In DMM, tumor necrosis is typically bland, consisting of areas of ischemic necrosis without significant inflammation or cellular debris (Figure 9), whereas in inflammatory pleural conditions like tuberculosis, the necrosis is typically associated with inflammatory cells and cellular debris. On occasion, benign reactive mesothelial hyperplasias may exhibit architectural features like papillary excrescences and tubular lumens that mimic the architectural patterns of DMM or other malignancies. There are some architectural clues that favor a benign proliferation over a malignancy. Papillary excrescences of benign hyperplastic mesothelial cells tend to be tufts of cells without true fibrovascular cores (Figure 10). Tubule-like structures in benign mesothelial proliferations tend to be small, simple, nonbranching structures (Figure 11), but it should be noted that some DMMs and metastatic carcinomas are also composed of small, simple, nonbranching tubules or glands. Complex branching tubules or glands favor malignancy (Figure 12). Histologic features strongly favoring a diagnosis of DMM over a benign reactive mesothelial hyperplasia are listed in Table 3. Invasion of underlying tissues is the most reliable criterion for the diagnosis of DMM, whether epithelial or sarcomatous. When invasion is minimal or equivocal, keratin immunostaining can help highlight the keratin-immunopositive neoplastic mesothelial cells infiltrating into underlying fat, connective tissue, or lung tissue (Figure 13). However, the mere fact that proliferating mesothelial cells are immunopositive for keratin, calretinin, or other markers does not make a diagnosis of benign versus malignant; the immunostains are used to demonstrate invasion of the cells into underlying tissues. In addition to invasion, certain other criteria favor malignancy, both epithelial and sarcomatous types. Obvious cellular nodules of neoplastic cells may expand into the stroma, or neoplastic cells may have such conspicuous malignant cytologic features (severe pleomorphism, abnormal mitoses) that a diagnosis of malignancy is warranted. Benign reactive mesothelial proliferations tend to demonstrate zonation; that is, the proliferating cells are found toward the pleural surface and the deeper tissues are more fibrotic (Figure 14). Finding mesothelial cells deep in the pleural connective tissue or through the full thickness of the pleura favors malignancy. Bland necrosis is characteristic of DMM, particularly the desmoplastic variety, which may otherwise be difficult to differentiate from fibrous pleuritis or pleural plaque. A soft criterion that favors a benign diagnosis is capillaries in a biopsy that are parallel to each other and that are perpendicular to the pleural surface (Figure 15). Capillaries in malignant mesotheliomas, particularly desmoplastic mesotheliomas, tend to be inconspicuous and arranged in a haphazard fashion. MIMICS OF INVASION Entrapment refers to benign reactive mesothelial cells that have remained on a previous pleural surface that is now covered by fibrinous, organizing, or fibrotic pleuritis, giving an impression of invasion. As layers of fibrin and/ or fibrous connective tissue spread over the pleural surface in an inflammatory process, the entrapped mesothelial cells tend to form linear arrays marking the site of the previous surface (Figures 16 and 17). In some cases, including when there are adhesions of the visceral and parietal surfaces, the reactive mesothelial cells may line elongated clefts that may sometimes resemble glands (Figure 18). Histologic features that favor entrapment of nonneoplastic mesothelial cells over invasion are listed in Table 4. Figure 11. Cytologically bland mesothelial cells line round to ovoid, simple, nonbranching tubules in this reactive proliferation (hematoxylineosin, original magnification 350). Figure 12. Complex branching tubules favor a diagnosis of diffuse malignant mesothelioma (hematoxylin-eosin, original magnification 150). Arch Pathol Lab Med Vol 129, November 2005 Mesothelial Proliferations on Pleural Biopsies Cagle & Churg 1425
6 Figure 13. Keratin immunostaining highlights microinvasion of keratin-positive mesothelioma cells into adipose tissue, confirming the malignant nature of the mesothelial proliferation (keratin, original magnification 350). Figure 14. Zonation characteristic of a benign process demonstrates proliferation of mesothelial cells, some forming simple nonbranching tubules, toward the pleural surface and absent in deeper fibrotic tissues (hematoxylin-eosin, original magnification 150) Arch Pathol Lab Med Vol 129, November 2005 Mesothelial Proliferations on Pleural Biopsies Cagle & Churg
7 Table 4. Histologic Features Favoring Nonneoplastic Entrapment Over Invasion Active fibrin deposition with active inflammation Linear arrays of individual cells and small glands Favors nonneoplastic entrapment Simple nonbranching glands Proliferating mesothelial cells separated by large amounts of stroma En face cuts of unoriented or poorly oriented pleural biopsies may also give a false impression of invasion. Sections cut parallel to the free serosal surface rather than at right angles to the surface may give the impression that benign surface reactive mesothelial cells are surrounded by connective tissue. This may be particularly difficult to recognize on small biopsies. As always, we urge caution when the possibility of an en face section cut is encountered. The presence of mesothelial cells on 2 surfaces is a clue that a specimen has been cut en face. IMMUNOHISTOCHEMICAL STUDIES Immunohistochemical examination is generally of little value in differentiating a benign reactive mesothelial proliferation from a DMM. As previously mentioned, broadspectrum keratin immunostains can be used to confirm invasion into underlying tissues such as adipose tissue when the hematoxylin-eosin stain is equivocal, but virtually all active benign mesothelial reactions are also keratin positive; what keratin stains really do is to show the distribution of mesothelial cells within the tissue. While there are a number of markers such as calretinin that often indicate a mesothelial origin, both reactive and malignant mesothelial proliferations stain positively. Although a number of markers such as p53 and epithelial membrane antigen have been proposed to provide secondary support of a diagnosis of malignancy on pleural biopsy, none of these markers is absolutely specific or sensitive and, therefore, cannot be relied on to make a diagnosis References 1. McCaughey WTE, Al-Jabi M. Differentiation of serosal hyperplasia and neoplasia in biopsies. Pathol Annu. 1986;21(pt 1): Tuder RM. Malignant disease of the pleura: a histopathological study with special emphasis on diagnostic criteria and differentiation from reactive mesothelium. Histopathology. 1986;10: Whitaker D, Henderson DW, Shilkin KB. The concept of mesothelioma in situ: implications for diagnosis and histogenesis. Semin Diagn Pathol. 1992;9: Henderson DW, Shilin KB, Whitaker D. Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ. Am J Clin Pathol. 1998;110: Mangano WE, Cagle PT, Churg A, Vollmer RT, Roggli VL. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistochemical analysis of 31 cases including p53 immunostaining. Am J Clin Pathol. 1998;110: Churg A, Colby TV, Cagle P, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol. 2000;24: Galateau-Sallé F, Cagle PT. Non-malignant versus malignant proliferations on pleural biopsy. In: Cagle PT, ed. Diagnostic Pulmonary Pathology. New York, NY: Marcel Dekker; 2000: Cagle PT. Pleural histology. In: Light RW, Lee YCG, eds. Pleural Disease: An International Textbook. London, England: Arnold Publishers; 2003: Cagle PT. Is there a preneoplastic mesothelial lesion? In: Vizjak A, Ferluga D, Bussolati G, eds. Update in Pathology. Ljubljana, Slovenia: University of Ljubljana; 2003: Churg A, Roggli V, Galateau-Salle F, et al. Tumours of the pleura: mesothelial tumours. In: Travis WD, Brambilla E, Harris CC, Muller-Hermelink HK, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; World Health Organization Classification of Tumours; vol Laga AC, Allen T, Bedrossian C, Laucirica R, Cagle PT. Reactive mesothelial hyperplasia. In: Cagle PT, editor-in-chief. The Color Atlas and Text of Pulmonary Pathology. New York, NY: Lippincott Williams & Wilkins; 2005: Churg A, Cagle PT, Roggli VL. Tumors of the Serosal Membranes. Washington, DC: Armed Forces Institute of Pathology. In press. Atlas of Tumor Pathology; 4th series, fascicle Galateau-Salle F, ed-in-chief; Brambilla E, Cagle PT, Churg A, et al, panel members. Pathology of Malignant Mesothelioma: An Update Prepared by the International Mesothelioma Panel. New York, NY: Springer Verlag. In press. 14. Mayall FG, Goddard H, Gibbs AR. p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections. J Pathol. 1992;168: Cagle PT, Brown RW, Lebovitz RM. p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens. Hum Pathol. 1994;25: Hurlimann J. Desmin and neural marker expression in mesothelial cells and mesotheliomas. Hum Pathol. 1994;25: Wolanski KD, Whitaker D, Shilkin KB, Henderson DW. The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses. Cancer. 1998;82: Davidson B, Nielsen S, Christensen J, et al. The role of desmin and N- cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol. 2001;25: Kumaki F, Kawai T, Churg A, et al. Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas. Am J Surg Pathol. 2002;26: Figure 15. In this reactive granulation tissue, capillaries and fibroblasts are parallel to one another and perpendicular to the pleural surface (hematoxylin-eosin, original magnification 350). Figure 16. Entrapment of benign reactive mesothelial cells occurs when organizing fibrin and blood (upper half of figure) layer over the pleural surface lined by reactive mesothelial cells (lower half of figure) (hematoxylin-eosin, original magnification 250). Figure 17. With organization of the overlying pleural exudates, proliferating mesothelial cells are entrapped between the pleura (lower portion of figure) and newly formed fibrous tissue (upper portion of figure). In this example, the entrapped reactive mesothelial cells are hyperplastic and form small nonbranching tubules (hematoxylin-eosin, original magnification 250). Figure 18. As the fibrous tissue matures, a linear array of entrapped mesothelial cells is present between the pleura and overlying fibrous tissue. Especially with adhesions, elongate lumens may be formed (hematoxylin-eosin, original magnification 150). Arch Pathol Lab Med Vol 129, November 2005 Mesothelial Proliferations on Pleural Biopsies Cagle & Churg 1427
Mesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016
Mesothelioma: diagnostic challenges from a pathological perspective Naseema Vorajee August 2016 Naseema.vorajee@nhls.ac.za Pleural diseases (whether neoplastic, reactive or infective) may have similar
More informationACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016
Diagnosing Mesothelioma in Limited Tissue Samples Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016 Sanja Dacic, MD, PhD University of Pittsburgh ACCME/Disclosures GENERAL RULES
More informationNotice of Faculty Disclosure
The Separation of Benign and Malignant Mesothelial Proliferations: Lessons from Morphology and Molecular Biology Andrew Churg, MD Departments of Pathology University of British Columbia & Vancouver General
More informationFrozen Section Library: Pleura
Frozen Section Library: Pleura For other titles published in this series, go to www.springer.com/series/7869 Frozen Section Library: Pleura Philip T. Cagle, MD Weill Medical College of Cornell University,
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More informationMesothelioma Pathobasic. Lukas Bubendorf Pathology
Mesothelioma Pathobasic Lukas Bubendorf Pathology Mechanisms of Asbestos Carcinogenesis in Mesothelioma Asprin High-mobility group protein B1 master switch HMGB1 Initiation/ perpetuation of inflamm. response
More informationWell-differentiated Papillary Mesothelioma of the Pleura Diagnosed by Video-Assisted Thoracic Surgical Pleural Biopsy : A Case Report
Showa Univ J Med Sci 25 1, 67 72, March 2013 Case Report Well-differentiated Papillary Mesothelioma of the Pleura Diagnosed by Video-Assisted Thoracic Surgical Pleural Biopsy : A Case Report Yuri TOMITA
More informationBiopsy Interpretation of Spindle cell proliferations of the Serosa
Biopsy Interpretation of Spindle cell proliferations of the Serosa Richard Attanoos, Cardiff. U.K. Disclosure of Relevant Financial Relationships USCAP requires that all planners (Education Committee)
More informationDisorders of Cell Growth & Neoplasia. Histopathology Lab
Disorders of Cell Growth & Neoplasia Histopathology Lab Paul Hanna April 2010 Case #84 Clinical History: 5 yr-old, West Highland White terrier. skin mass from axillary region. has been present for the
More informationProliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London
Proliferative Epithelial lesions of the Breast Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London Amman, November2013 Proliferative Epithelial Lesions of the Breast Usual type
More informationHistopathology: skin pathology
Histopathology: skin pathology These presentations are to help you identify, and to test yourself on identifying, basic histopathological features. They do not contain the additional factual information
More informationUpdate on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.
1 Our speaker for this program is Dr. Anja Roden, an associate professor of Laboratory Medicine and Pathology at Mayo Clinic as well as consultant in the Anatomic Pathology Laboratory and co-director of
More informationPathology of the pleura: What the pulmonologists need to knowresp_1957
430..438 INVITED REVIEW SERIES: PLEURAL DISEASE SERIES EDITORS: JOSÉ M. PORCEL AND Y.C. GARY LEE Pathology of the pleura: What the pulmonologists need to knowresp_1957 PHILIP T. CAGLE 1,2 AND TIMOTHY CRAIG
More informationACCME/Disclosures. Case 4 USCAP Pulmonary Panel Case 4 History
Case 4 USCAP Pulmonary Panel 2016 Andrew Churg, MD Department of Pathology Vancouver General Hospital & University of British Columbia Vancouver, BC achurg@mail.ubc.ca. ACCME/Disclosures The USCAP requires
More informationARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.
1 ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY Jonathan I. Epstein Professor Pathology, Urology, Oncology The Reinhard Professor of Urological
More informationMorphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens
ISPUB.COM The Internet Journal of Pathology Volume 12 Number 1 Morphologic Criteria of Invasive Colonic Adenocarcinoma on Biopsy Specimens C Rose, H Wu Citation C Rose, H Wu.. The Internet Journal of Pathology.
More informationDisclosures. Parathyroid Pathology. Objectives. The normal parathyroid 11/10/2012
Disclosures Parathyroid Pathology I have nothing to disclose Annemieke van Zante MD/PhD Assistant Professor of Clinical Pathology Associate Chief of Cytopathology Objectives 1. Review the pathologic features
More informationDemystifying Endometrial Hyperplasia
Demystifying Endometrial Hyperplasia A review from Diagnostic Histopathology 19:7 Dr R Hadden ST5 Histopathology Derriford Hospital Plymouth Endometrium Target for sex-steroid hormones Glands Stroma Proliferate
More informationDiseases of the breast (1 of 2)
Diseases of the breast (1 of 2) Introduction A histology introduction Normal ducts and lobules of the breast are lined by two layers of cells a layer of luminal cells overlying a second layer of myoepithelial
More informationIntraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
& 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and
More informationAmong the benign intraepithelial melanocytic proliferations, Inflamed Conjunctival Nevi. Histopathological Criteria. Resident Short Reviews
Resident Short Reviews Inflamed conjunctival nevi (ICN) may suggest malignancy because of their rapid growth and atypical histology. The objective of this study was to characterize the diagnostic features
More informationBasal cell carcinoma 5/28/2011
Goal of this Presentation A practical approach to the diagnosis of cutaneous carcinomas and their mimics Thaddeus Mully, MD University of California San Francisco To review common non-melanoma skin cancers
More informationA 25 year old female with a palpable mass in the right lower quadrant of her abdomen
May 2016 A 25 year old female with a palpable mass in the right lower quadrant of her abdomen Contributed by: Paul Ndekwe, MD, Resident Physician, Indiana University School of Department of Pathology and
More information1 NORMAL HISTOLOGY AND METAPLASIAS
1 NORMAL HISTOLOGY AND METAPLASIAS, MD Anatomy and Histology 1 Metaplasias 2 ANATOMY AND HISTOLOGY The female breast is composed of a branching duct system, which begins at the nipple with the major lactiferous
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More informationHistopathology: Cervical HPV and neoplasia
Histopathology: Cervical HPV and neoplasia These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about
More informationDIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES
DIAGNOSTIC SLIDE SEMINAR: PART 1 RENAL TUMOUR BIOPSY CASES Dr. Andrew J. Evans MD, PhD, FACP, FRCPC Consultant in Genitourinary Pathology University Health Network, Toronto, ON Case 1 43 year-old female,
More informationTumors of the Lungs and Pleura
5 Tumors of the Lungs and Pleura Saul Suster and Cesar Moran Introduction Carcinoma of the lung is a common malignant tumor. Histological typing of lung tumors has long been a source of controversy in
More informationPrimary pleural tumors occur uncommonly in both children
Review and Update of Uncommon Primary Pleural Tumors A Practical Approach to Diagnosis Laura Granville, MD; Alvaro C. Laga, MD; Timothy Craig Allen, MD, JD; Megan Dishop, MD; Victor L. Roggli, MD; Andrew
More informationReactive mesothelial proliferation: a necropsy study
Thorax 1981 ;36:901-905 Reactive mesothelial proliferation: a necropsy study CD SHELDON, AMANDA HERBERT, PJ GALLAGHER From the Department ofpathology, Southampton University General Hospital, Southampton
More information5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.
Common Differential Diagnoses in Urological Pathology Jonathan I. Epstein Prostate Adenocarcinoma vs. Urothelial Carcinoma 1 2 NKX3.1 NKX3.1 3 4 5 6 Proposed ISUP Recommendations Option to use PSA as a
More informationDucts of Luschka as a Mimicker of Well-Differentiated Adenocarcinoma of Gallbladder: A Case Report and Review of Literature
North American Journal of Medicine and Science Oct 2016 Vol 9 No.4 187 Case Report Ducts of Luschka as a Mimicker of Well-Differentiated Adenocarcinoma of Gallbladder: A Case Report and Review of Literature
More informationNeoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath
Neoplasia 2018 Lecture 2 Dr Heyam Awad MD, FRCPath ILOS 1. List the differences between benign and malignant tumors. 2. Recognize the histological features of malignancy. 3. Define dysplasia and understand
More informationGuidelines for Pathologic Diagnosis of Malignant Mesothelioma. A Consensus Statement from the International Mesothelioma Interest Group
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma A Consensus Statement from the International Mesothelioma Interest Group Aliya N. Husain, MD; Thomas V. Colby, MD; Nelson G. Ordóñez, MD; Thomas
More informationDesmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC
R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o
More informationSESSION 1: GENERAL (BASIC) PATHOLOGY CONCEPTS Thursday, October 16, :30am - 11:30am FACULTY COPY
SESSION 1: GENERAL (BASIC) PATHOLOGY CONCEPTS Thursday, October 16, 2008 9:30am - 11:30am FACULTY COPY GOAL: Describe the basic morphologic (structural) changes which occur in various pathologic conditions.
More informationDiplomate of the American Board of Pathology in Anatomic and Clinical Pathology
A 33-year-old male with a left lower leg mass. Contributed by Shaoxiong Chen, MD, PhD Assistant Professor Indiana University School of Medicine/ IU Health Partners Department of Pathology and Laboratory
More informationNew Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology
New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology United States and Canadian Academy of Pathology 102 nd Annual Meeting Baltimore, Maryland Christina S. Kong, M.D.
More informationGross appearance of peritoneal cysts. They have a thin, translucent wall and contain a clear fluid.
Gross appearance of peritoneal cysts. They have a thin, translucent wall and contain a clear fluid. So-called multicystic benign mesothelioma. A, Gross appearance. So-called multicystic benign mesothelioma.
More informationMody. AIS vs. Invasive Adenocarcinoma of the Cervix
Common Problems in Gynecologic Pathology Michael T. Deavers, M.D. Houston Methodist Hospital, Houston, Texas Common Problems in Gynecologic Pathology Adenocarcinoma in-situ (AIS) of the Cervix vs. Invasive
More information6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies
Outline of Talk Lobular Breast Cancer: Common Problems in Diagnosing LCIS in Core Biopsies Definition of lobular differentiation Variants of LCIS that: carry risk for unsampled invasive cancer mimic DCIS
More informationProtocol for the Examination of Specimens From Patients With Primary Malignant Tumors of the Heart
Protocol for the Examination of Specimens From Patients With Primary Malignant Tumors of the Heart Protocol applies to primary malignant cardiac tumors. Hematolymphoid neoplasms are not included. No AJCC/UICC
More informationGastrooesophageal reflux disease. Jera Jeruc Institute of pathology, Faculty of Medicine, Ljubljana, Slovenia
Gastrooesophageal reflux disease Jera Jeruc Institute of pathology, Faculty of Medicine, Ljubljana, Slovenia Reflux esophagitis (RE) GERD: a spectrum of clinical conditions and histologic alterations resulting
More informationBenign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more
Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more common on the trunk; but extremities, head and neck are
More informationWedge Biopsy for Diffuse Lung Diseases
Chapter VI Wedge Biopsy for Diffuse Lung Diseases Wedge biopsy via thoracoscopic biopsy or open lung biopsy is occasionally performed to obtain tissue for the diagnosis of a diffuse lung disease. A wedge
More information5/21/2018. Difficulty in Underdiagnosing Prostate Cancer. Diagnosis of Prostate Cancer. Evaluation of Prostate Cancer and Atypical on Needle Biopsy
Evaluation of Prostate Cancer and Atypical on Needle Biopsy Jonathan I. Epstein Difficulty in Underdiagnosing Prostate Cancer Limited tissue on needle biopsy (1 cm. x
More informationThe pathologic diagnosis of malignant mesothelioma
Review Articles Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group Aliya Noor Husain, MD; Thomas V.
More informationObjectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells
2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate
More informationGross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of
Tiền liệt tuyến Tiền liệt tuyến Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of solid and microcystic areas.
More informationCase year female. Routine Pap smear
Case 1 57 year female Routine Pap smear Diagnosis? 1. Atypical glandular cells of unknown significance (AGUS) 2. Endocervical AIS 3. Endocervical adenocarcinoma 4. Endometrial adenocarcinoma 5. Adenocarcinoma
More informationValue of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions
Romanian Journal of Morphology and Embryology 2006, 47(4):351 355 ORIGINAL PAPER Value of antimesothelioma HBME 1 in the diagnosis of inflammatory and malignant pleural effusions LILIANA MOCANU 1), ANCA
More informationLARYNGEAL DYSPLASIA. Tomas Fernandez M; 3 rd year ENT resident, Son Espases University Hospital
LARYNGEAL DYSPLASIA Tomas Fernandez M; 3 rd year ENT resident, Son Espases University Hospital INTRODUCTION Laryngeal cancer constitutes 1-2% of all malignancies diagnosed worldwide Survival is related
More information3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:
GU Evening Subspecialty Case Conference Rajal B. Shah, M.D. VP, Medical Director, Urologic Pathology Miraca Life Sciences, Irving, Texas Clinical Associate Professor of Pathology Baylor College of Medicine,
More informationnumber Done by Corrected by Doctor Maha Shomaf
number 16 Done by Waseem Abo-Obeida Corrected by Zeina Assaf Doctor Maha Shomaf MALIGNANT NEOPLASMS The four fundamental features by which benign and malignant tumors can be distinguished are: 1- differentiation
More informationAtypical Hyperplasia/EIN
EIN Atypical Hyperplasia/EIN Based on scientific and diagnostic advances, in 2014 the WHO moved that the precursor lesion for endometrioid carcinoma be atypical hyperplasia/ein, rather than what was previously
More informationTwo malignant pleural mesotheliomas with unusual histological features
Thorax, 1979, 34, 375-379 Two malignant pleural mesotheliomas with unusual histological features B GOLDSTEIN From the National Research Institute for Occupational Diseases of the South African Medical
More informationWhen Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box?
When Immunostains Can Get You in Trouble: Gynecologic Pathology p16: Panacea or Pandora s Box? Teri A. Longacre, MD Stanford Medicine Stanford California pi6 in Gynecologic Pathology: Panacea or Pandora
More information04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA
Intraductal Papillary Neoplasms Of Breast Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head The University of Texas MD Anderson Cancer Center 25 th Annual Seminar in Pathology Pittsburgh,
More informationPresentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98
Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation
More informationSynonyms. Nephrogenic metaplasia Mesonephric adenoma
Nephrogenic Adenoma Synonyms Nephrogenic metaplasia Mesonephric adenoma Definition Benign epithelial lesion of urinary tract with tubular, glandular, papillary growth pattern Most frequently in the urinary
More informationIntroduction. 23 rd Annual Seminar in Pathology. FLUIDS, Part 1. Pittsburgh, PA Gladwyn Leiman UVMMC, VT
23 rd Annual Seminar in Pathology Pittsburgh, PA Gladwyn Leiman UVMMC, VT FLUIDS, Part 1 "Blue walls", Claudia Hansen, 2009 Introduction o Challenging to everyone o Almost any benign or malignant process
More informationPSA. HMCK, p63, Racemase. HMCK, p63, Racemase
Case 1 67 year old male presented with gross hematuria H/o acute prostatitis & BPH Urethroscopy: small, polypoid growth with a broad base emanating from the left side of the verumontanum Serum PSA :7 ng/ml
More informationAlthough current American Cancer Society guidelines
ORIGINAL ARTICLE Diffuse Adenosis of the Peripheral Zone in Prostate Needle Biopsy and Prostatectomy Specimens Tamara L. Lotan, MD* and Jonathan I. Epstein, MD*w z Abstract: We have observed a group of
More informationMalignant Peripheral Nerve Sheath Tumor
C H A P T E R 120 Malignant Peripheral Nerve Sheath Tumor Currently, malignant peripheral nerve sheath tumor (MPNST) is the most commonly used generic name for the neoplasms known in the past as neurosarcoma,
More informationNeuroendocrine Lung Tumors Myers
Diagnosis and Classification of Neuroendocrine Lung Tumors Jeffrey L. Myers, M.D. A. James French Professor Director, Anatomic Pathology & MLabs University of Michigan, Ann Arbor, MI myerjeff@umich.edu
More informationPrepared By Jocelyn Palao and Layla Faqih
Prepared By Jocelyn Palao and Layla Faqih The structure of the suspected atypical cell should always be compared to the structure of other similar, benign, cells which are present in the smears. The diagnosis
More informationImmunohistochemistry on Fluid Specimens: Technical Considerations
Immunohistochemistry on Fluid Specimens: Technical Considerations Blake Gilks Dept of Pathology University of British Columbia, Vancouver, BC, Canada Disclosures None Learning Objectives At the end of
More informationLung Cytology: Lessons Learned from Errors in Practice
Lung Cytology: Lessons Learned from Errors in Practice Stephen S. Raab, M.D. Department of Laboratory Medicine Eastern Health and Memorial University of Newfoundland, St. John s, NL and University of Washington,
More informationMalignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry
766 J Clin Pathol 2001;54:766 770 Malignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry Department of Pathology, Victoria Infirmary, Langside
More informationCase # year old man with a 2 cm right kidney mass
Case # 4. 52 year old man with a 2 cm right kidney mass Figure 1 Figure 2 Figure 3 Figure 4 Diagnosis: Negative/Non-diagnostic Normal kidney tissue Fine needle aspiration (FNA) of the kidney is performed
More informationUrinary Bladder: WHO Classification and AJCC Staging Update 2017
Urinary Bladder: WHO Classification and AJCC Staging Update 2017 Houston Society of Clinical Pathologists 58 th Annual Spring Symposium Houston, TX April 8, 2017 Jesse K. McKenney, MD Classification
More information04/09/2018. Squamous Cell Neoplasia and Precursor Lesions. Agenda. Squamous Dysplasia. Squamo-proliferative lesions. Architectural features
Squamous Cell Neoplasia and Precursor Lesions Jennifer L. Hunt, MD, MEd Aubrey J. Hough Jr, MD, Endowed Professor of Pathology Chair of Pathology and Laboratory Medicine University of Arkansas for Medical
More informationNormal endometrium: A, proliferative. B, secretory.
Normal endometrium: A, proliferative. B, secretory. Nội mạc tử cung Nội mạc tử cung Cyclic changes in endometrium.. Approximate relationship of useful microscopic changes. Arias-Stella reaction in endometrial
More informationCPC 4 Breast Cancer. Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast.
CPC 4 Breast Cancer Rochelle Harwood, a 35 year old sales assistant, presents to her GP because she has noticed a painless lump in her left breast. 1. What are the most likely diagnoses of this lump? Fibroadenoma
More informationDuctal Proliferations of the Breast: The Good, the Bad, and the Ugly
Ductal Proliferations of the Breast: The Good, the Bad, and the Ugly Melinda F. Lerwill, MD CRITERIA FOR DISTINGUISHING LOW-GRADE DUCTAL CARCINOMA IN SITU FROM USUAL DUCTAL HYPERPLASIA CYTOLOGY Low-grade
More informationLung Tumor Cases: Common Problems and Helpful Hints
Lung Tumor Cases: Common Problems and Helpful Hints Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona Society of Pathologists
More informationCLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES
Papillomas. Papillomas are composed of multiple branching fibrovascular cores, each having a connective tissue axis lined by luminal and myoepithelial cells ( Fig. 23-11 ). Growth occurs within a dilated
More informationEpithelial Columnar Breast Lesions: Histopathology and Molecular Markers
29th Annual International Conference Advances in the Application of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells 25 th -27t h June, 2012, Mykonos, Greece Epithelial Columnar
More informationEARLY ONLINE RELEASE
EARLY ONLINE RELEASE Note: This article was posted on the Archives Web site as an Early Online Release. Early Online Release articles have been peer reviewed, copyedited, and reviewed by the authors. Additional
More informationMammary Nodular Hyperplasia in Intact R hesus Monkeys
Vet. Path. 10: 130-134 (1973) Mammary Nodular Hyperplasia in Intact R hesus Monkeys L. W NELSON and L. D. SHOTT Department of Pathology and Toxicology, Mead Johnson Research Center, Evansville, Ind., and
More informationCell-Adhesion Molecule Expression and the Proliferation of Malignant Mesothelioma: A Post-Mortem Examination
Cell-Adhesion Molecule Expression and the Proliferation of Malignant Mesothelioma: A Post-Mortem Examination KOZO KURIBAYASHI 1*, HIROSHI HIRANO 2*, KEIJI NAKASHO 3, HIDEKI OHYAMA 3, KOJI YAMANEGI 3, CHIHARU
More informationCytyc Corporation - Case Presentation Archive - March 2002
FirstCyte Ductal Lavage History: 68 Year Old Female Gail Index: Unknown Clinical History: Negative Mammogram in 1995 6 yrs. later presents with bloody nipple discharge Subsequent suspicious mammogram Suspicious
More informationDisclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1
Disclosure Relevant Financial Relationship(s) None Off Label Usage None 2013 MFMER slide-1 Case Presentation A 43 year old male, with partial nephrectomy for a right kidney mass 2013 MFMER slide-2 2013
More informationCASE REPORT Malignant transformation of breast ductal adenoma: a diagnostic pitfall
Malaysian J Pathol 2015; 37(3) : 281 285 CASE REPORT Malignant transformation of breast ductal adenoma: a diagnostic pitfall Hiroko HAYASHI, Hiroshi OHTANI,* Junzo YAMAGUCHI,** and Isao SHIMOKAWA Department
More informationMyxo-inflammatory Fibroblastic sarcoma
AKA Myxo-inflammatory Fibroblastic sarcoma Acral Myxoinflammatory fibroblastic sarcomaam.j.surg.path1998; 22; 911-924 Inflammatory myxoid tumour of soft parts with bizarre giant cells [Pathol.Res.Pract.
More informationUpdate on Thyroid FNA The Bethesda System. Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center
Update on Thyroid FNA The Bethesda System Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center Thyroid Nodules Frequent occurrence Palpable: 4-7% of adults Ultrasound: 10-31% Majority benign
More informationThe Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin
The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin 24.06.15 Norman Barrett Smiles [A brief digression - Chair becoming
More informationCINtec p16 INK4a Staining Atlas
CINtec p16 INK4a Staining Atlas Rating Rating Positive The rating positive will be assigned if the p16 INK4a -stained slide shows a continuous staining of cells of the basal and parabasal cell layers of
More informationKidney Case 1 SURGICAL PATHOLOGY REPORT
Kidney Case 1 Surgical Pathology Report February 9, 2007 Clinical History: This 45 year old woman was found to have a left renal mass. CT urography with reconstruction revealed a 2 cm medial mass which
More informationPAPILLARY PROLIFERATION OF THE ENDOMETRIUM: A BENIGN LESION SIMULATING ADENOCARCINOMA.
PAPILLARY PROLIFERATION OF THE ENDOMETRIUM: A BENIGN LESION SIMULATING ADENOCARCINOMA. Teresa Pusiol, Maria Grazia Zorzi, Doriana Morichetti U.O. Anatomia Patologica Ospedale S. Maria del Carmine Rovereto
More informationAs part of the International Mesothelioma Interest Group
Review Articles Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group Aliya N. Husain, MD; Thomas Colby,
More informationINDEX. surgpath.theclinics.com. Note: Page numbers of article titles are in boldface type. diffuse pleural fibrosis, pleural plaques,
INDEX Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, minimally invasive. See Minimally invasive adenocarcinoma (MIA). Airway-centered interstitial fibrosis, 183 184 ALK (anaplastic
More informationRespiratory Tract Cytology
Respiratory Tract Cytology 40 th European Congress of Cytology Liverpool, UK Momin T. Siddiqui M.D. Professor of Pathology and Laboratory Medicine Director of Cytopathology Emory University Hospital, Atlanta,
More informationAggressive Malignant Mesothelioma In A Patient Without Previous Asbestos Exposure
ISPUB.COM The Internet Journal of Pathology Volume 19 Number 1 Aggressive Malignant Mesothelioma In A Patient Without Previous Asbestos Exposure A Julai, G Wathuge Citation A Julai, G Wathuge. Aggressive
More informationGood afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting
PATHOLOGY IN-SITU CARCINOMA, ROHIT BHARGAVA, MD 1 Good afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting me here, it s great to be here and I m going to talk about
More informationPulmonary Adenofibroma: Report of a Case with Multiple Masses
Available online at www.annclinlabsci.org Pulmonary Adenofibroma: Report of a Case with Multiple Masses Junmei Hao 1, Cuiping Zhang 1, Qinghua Cao 1, Jiarui Zou 1, and Chaofu Wang 2 1 Department of Pathology,
More informationDysplasia, Mimics and Other Controversies
Dysplasia, Mimics and Other Controversies Mary S. Richardson, MD Dept. of Pathology Medical University of South Carolina Charleston, SC Notice of Faculty Disclosure In accordance with ACGME guidelines,
More informationNeoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture
Neoplasia part I By Dr. Mohsen Dashti Clinical Medicine & Pathology 316 2 nd Lecture Lecture outline Review of structure & function. Basic definitions. Classification of neoplasms. Morphologic features.
More informationA neoplasm is defined as "an abnormal tissue proliferation, which exceeds that of adjacent normal tissue. This proliferation continues even after
NEOPLASIA Neoplasia is a very important topic in pathology because neoplasms are both common and serious diseases. A neoplasm literally means a new growth, and this term is used interchangeably with a
More informationAtypical Regenerative Hyperplasia of the Esophagus in Endoscopic Biopsy. A Mimicker of Squamous Esophagic Carcinoma
Atypical Regenerative Hyperplasia of the Esophagus in Endoscopic Biopsy A Mimicker of Squamous Esophagic Carcinoma Julián Arista-Nasr, MD; Irene Rivera, MD; Braulio Martinez-Benitez, MD; Leticia Bornstein-Quevedo,
More information